Whereas, in the high TTK group, 15(53.6%) were in TNM stages I-II, and 13 (46.4%) were in TNM stages III-IV, indicating that high TTK expression is significantly associated with advanced TNM stage in NSCLC (P=0.015, Table 1). The gene discussed is TTK; the disease is non-small cell lung carcinoma.